Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-08-12 Sale |
2022-08-16 4:15 pm |
Mirati Therapeutics Inc. | MRTX | CARTER BRUCE L A Director |
10,000 | $85.49 | $854,899 | 6,021 (Direct) |
View |
| 2022-05-23 Sale |
2022-06-14 4:35 pm |
Mirati Therapeutics Inc. | MRTX | Christensen Jamie EVP, Chief Scientific Officer |
624 | $63.54 | $39,649 | 86,804 (Direct) |
View |
| 2022-02-11 Sale |
2022-02-14 4:51 pm |
Mirati Therapeutics Inc. | MRTX | FUCHS HENRY J Director |
11,000 | $105.61 | $1,161,717 | 6,021 (Direct) |
View |
| 2022-01-19 Sale |
2022-01-20 4:57 pm |
Mirati Therapeutics Inc. | MRTX | Cherrington Julie M Director |
1,475 | $116.07 | $171,203 | 2,546 (Direct) |
View |
| 2022-01-18 Sale |
2022-01-18 8:34 pm |
Mirati Therapeutics Inc. | MRTX | REED VICKIE S SVP, Chief Accounting Officer |
533 | $120.48 | $64,217 | 24,279 (Direct) |
View |
| 2022-01-18 Sale |
2022-01-18 8:33 pm |
Mirati Therapeutics Inc. | MRTX | Christensen Jamie EVP, Chief Scientific Officer |
627 | $120.51 | $75,558 | 105,249 (Direct) |
View |
| 2022-01-18 Sale |
2022-01-18 8:32 pm |
Mirati Therapeutics Inc. | MRTX | BAUM CHARLES M President,Founder,Head of R&D |
2,517 | $120.48 | $303,253 | 348,276 (Direct) |
View |
| 2022-01-18 Sale |
2022-01-18 8:32 pm |
Mirati Therapeutics Inc. | MRTX | Hickey Benjamin EVP, Chief Commercial Officer |
627 | $120.48 | $75,543 | 52,797 (Direct) |
View |
| 2022-01-07 Sale |
2022-01-07 8:27 pm |
Mirati Therapeutics Inc. | MRTX | Hickey Benjamin EVP, Chief Commercial Officer |
1,964 | $135.94 | $266,984 | 24,848 (Direct) |
View |
| 2022-01-07 Sale |
2022-01-07 8:26 pm |
Mirati Therapeutics Inc. | MRTX | REED VICKIE S SVP, Chief Accounting Officer |
345 | $135.94 | $46,900 | 10,525 (Direct) |
View |
| 2022-01-04 Sale |
2022-01-06 4:51 pm |
Mirati Therapeutics Inc. | MRTX | BAUM CHARLES M President,Founder,Head of R&D |
4,114 | $147.75 | $607,855 | 101,170 (Direct) |
View |
| 2022-01-04 Sale |
2022-01-06 4:51 pm |
Mirati Therapeutics Inc. | MRTX | Christensen Jamie EVP, Chief Scientific Officer |
1,442 | $147.72 | $213,017 | 77,300 (Direct) |
View |
| 2022-01-04 Sale |
2022-01-06 4:50 pm |
Mirati Therapeutics Inc. | MRTX | REED VICKIE S SVP, Chief Accounting Officer |
758 | $147.74 | $111,987 | 10,870 (Direct) |
View |
| 2021-12-06 Sale |
2021-12-07 5:52 pm |
Mirati Therapeutics Inc. | MRTX | Christensen Jamie EVP, Chief Scientific Officer |
1,201 | $130.79 | $157,078 | 59,505 (Direct) |
View |
| 2021-12-03 Sale |
2021-12-03 8:09 pm |
Mirati Therapeutics Inc. | MRTX | BAUM CHARLES M President & Head of R&D |
47,204 | $133.2 | $6,287,687 | 112,714 (Direct) |
View |
| 2021-06-18 Sale |
2021-06-21 5:12 pm |
Mirati Therapeutics Inc. | MRTX | BAUM CHARLES M President & CEO |
40,000 | $165.46 | $6,618,233 | 159,918 (Direct) |
View |
| 2021-05-24 Sale |
2021-05-25 6:04 pm |
Mirati Therapeutics Inc. | MRTX | Christensen Jamie EVP, Chief Scientific Officer |
435 | $154.34 | $67,138 | 53,850 (Direct) |
View |
| 2021-04-05 Sale |
2021-04-06 8:06 pm |
Mirati Therapeutics Inc. | MRTX | CARTER BRUCE L A Director |
2,250 | $177.11 | $398,507 | 3,475 (Direct) |
View |
| 2021-03-19 Sale |
2021-03-22 4:42 pm |
Mirati Therapeutics Inc. | MRTX | Hickey Benjamin EVP, Chief Commercial Officer |
2,369 | $176.44 | $417,978 | 56,928 (Direct) |
View |
| 2021-03-09 Sale |
2021-03-10 9:30 pm |
Mirati Therapeutics Inc. | MRTX | Braslyn Ltd. LEWIS JOSEPH 10% Owner |
12,381 | $197.64 | $2,446,924 | 10,292,456 (Direct) |
View |
| 2021-03-05 Sale |
2021-03-09 9:48 pm |
Mirati Therapeutics Inc. | MRTX | Boxer Capital LLC Boxer Asset Management Inc. LEWIS JOSEPH MVA Investors LLC Davis Aaron I. LIEBERBURG IVAN M Dissanayake Shehan Bharatha Fuglesang Christopher 10% Owner |
400,005 | $181.15 | $72,460,905 | 2,332,809 (Direct) |
View |
| 2021-03-02 Sale |
2021-03-04 5:25 pm |
Mirati Therapeutics Inc. | MRTX | Cherrington Julie M Director |
2,000 | $201.01 | $402,020 | 1,475 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-09-07 Option Award |
2022-09-09 5:35 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | Christensen Jamie EVP, Chief Scientific Officer |
19,149 | $0 | 106,089 (Direct) |
View |
| 2022-08-12 Exercise |
2022-08-16 4:15 pm |
N/A 2028-01-17 |
Mirati Therapeutics Inc. | MRTX | CARTER BRUCE L A Director |
10,000 | $0 | 6,021 (Direct) |
View |
| 2022-08-12 Exercise |
2022-08-16 4:15 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | CARTER BRUCE L A Director |
10,000 | $27 | 6,021 (Direct) |
View |
| 2022-06-01 Option Award |
2022-06-03 5:56 pm |
N/A 2032-05-31 |
Mirati Therapeutics Inc. | MRTX | Stelzer Laurie CFO |
148,962 | $0 | 148,962 (Direct) |
View |
Ownership |
2022-05-16 5:01 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | Stelzer Laurie CFO |
0 | $0 | 0 (Direct) |
View |
| 2022-02-11 Exercise |
2022-02-14 4:51 pm |
2017-09-09 2024-09-08 |
Mirati Therapeutics Inc. | MRTX | FUCHS HENRY J Director |
11,000 | $0 | 6,021 (Direct) |
View |
| 2022-02-11 Exercise |
2022-02-14 4:51 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | FUCHS HENRY J Director |
11,000 | $20.54 | 6,021 (Direct) |
View |
| 2022-01-14 Option Award |
2022-01-18 8:34 pm |
N/A 2032-01-13 |
Mirati Therapeutics Inc. | MRTX | REED VICKIE S SVP, Chief Accounting Officer |
14,287 | $0 | 24,279 (Direct) |
View |
| 2022-01-14 Option Award |
2022-01-18 8:33 pm |
N/A 2032-01-13 |
Mirati Therapeutics Inc. | MRTX | Christensen Jamie EVP, Chief Scientific Officer |
28,576 | $0 | 105,249 (Direct) |
View |
| 2022-01-18 Exercise |
2022-01-18 8:32 pm |
N/A 2028-01-17 |
Mirati Therapeutics Inc. | MRTX | BAUM CHARLES M President,Founder,Head of R&D |
3,703 | $0 | 348,276 (Direct) |
View |
| 2022-01-14 Option Award |
2022-01-18 8:32 pm |
N/A 2032-01-13 |
Mirati Therapeutics Inc. | MRTX | BAUM CHARLES M President,Founder,Head of R&D |
67,868 | $0 | 348,276 (Direct) |
View |
| 2022-01-18 Exercise |
2022-01-18 8:32 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | BAUM CHARLES M President,Founder,Head of R&D |
3,703 | $27 | 348,276 (Direct) |
View |
| 2022-01-14 Option Award |
2022-01-18 8:32 pm |
N/A 2032-01-13 |
Mirati Therapeutics Inc. | MRTX | Hickey Benjamin EVP, Chief Commercial Officer |
28,576 | $0 | 52,797 (Direct) |
View |
| 2022-01-14 Option Award |
2022-01-18 8:32 pm |
N/A 2032-01-13 |
Mirati Therapeutics Inc. | MRTX | Hasnain Faheem Director |
8,862 | $0 | 13,960 (Direct) |
View |
| 2022-01-14 Option Award |
2022-01-18 6:21 pm |
N/A 2032-01-13 |
Mirati Therapeutics Inc. | MRTX | CARTER BRUCE L A Director |
6,234 | $0 | 9,709 (Direct) |
View |
| 2022-01-14 Option Award |
2022-01-18 6:21 pm |
N/A 2032-01-13 |
Mirati Therapeutics Inc. | MRTX | FUCHS HENRY J Director |
6,234 | $0 | 9,709 (Direct) |
View |
| 2022-01-14 Option Award |
2022-01-18 6:20 pm |
N/A 2032-01-13 |
Mirati Therapeutics Inc. | MRTX | Johnson Craig A Director |
6,234 | $0 | 9,709 (Direct) |
View |
| 2022-01-14 Option Award |
2022-01-18 6:20 pm |
N/A 2032-01-13 |
Mirati Therapeutics Inc. | MRTX | Martinez Maria E Director |
6,234 | $0 | 9,709 (Direct) |
View |
| 2022-01-14 Option Award |
2022-01-18 6:20 pm |
N/A 2032-01-13 |
Mirati Therapeutics Inc. | MRTX | Meek David D. Chief Executive Officer |
90,490 | $0 | 90,490 (Direct) |
View |
| 2022-01-14 Option Award |
2022-01-18 6:19 pm |
N/A 2032-01-13 |
Mirati Therapeutics Inc. | MRTX | Cherrington Julie M Director |
6,234 | $0 | 7,709 (Direct) |
View |
| 2022-01-14 Option Award |
2022-01-18 6:17 pm |
N/A 2032-01-13 |
Mirati Therapeutics Inc. | MRTX | Davis Aaron I. Director 10% Owner |
6,234 | $0 | 46,761 (Direct) |
View |
| 2022-01-14 Option Award |
2022-01-18 6:17 pm |
N/A 2032-01-13 |
Mirati Therapeutics Inc. | MRTX | Sharp Shalini Director |
6,234 | $0 | 8,658 (Direct) |
View |
| 2021-12-16 Gift |
2021-12-17 7:10 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | BAUM CHARLES M President & CEO |
7,430 | $0 | 105,284 (Direct) |
View |
| 2021-12-16 Option Award |
2021-12-17 7:10 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | Christensen Jamie EVP, Chief Scientific Officer |
19,149 | $0 | 78,742 (Direct) |
View |
| 2021-12-03 Option Award |
2021-12-07 5:52 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | Christensen Jamie EVP, Chief Scientific Officer |
6,856 | $0 | 59,505 (Direct) |
View |
| 2021-12-03 Exercise |
2021-12-03 8:09 pm |
2017-05-09 2022-11-12 |
Mirati Therapeutics Inc. | MRTX | BAUM CHARLES M President & Head of R&D |
47,204 | $0 | 112,714 (Direct) |
View |
| 2021-12-03 Exercise |
2021-12-03 8:09 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | BAUM CHARLES M President & Head of R&D |
47,204 | $8.49 | 112,714 (Direct) |
View |
| 2021-09-22 Option Award |
2021-09-24 5:11 pm |
N/A 2031-09-21 |
Mirati Therapeutics Inc. | MRTX | Meek David D. Chief Executive Officer |
150,300 | $0 | 150,300 (Direct) |
View |
| 2021-06-18 Exercise |
2021-06-21 5:12 pm |
2017-05-09 2022-11-12 |
Mirati Therapeutics Inc. | MRTX | BAUM CHARLES M President & CEO |
40,000 | $0 | 159,918 (Direct) |
View |
| 2021-06-18 Exercise |
2021-06-21 5:12 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | BAUM CHARLES M President & CEO |
40,000 | $8.49 | 159,918 (Direct) |
View |
| 2021-04-05 Exercise |
2021-04-06 8:06 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | CARTER BRUCE L A Director |
2,250 | $6.78 | 3,475 (Direct) |
View |
| 2021-04-05 Exercise |
2021-04-06 8:06 pm |
2019-09-27 2026-09-26 |
Mirati Therapeutics Inc. | MRTX | CARTER BRUCE L A Director |
2,250 | $0 | 3,475 (Direct) |
View |
| 2021-03-26 Option Award |
2021-03-30 5:41 pm |
N/A 2031-03-25 |
Mirati Therapeutics Inc. | MRTX | Sharp Shalini Director |
5,947 | $0 | 5,947 (Direct) |
View |
Ownership |
2021-03-30 5:41 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | Sharp Shalini Director |
0 | $0 | 0 (Direct) |
View |
| 2021-03-19 Exercise |
2021-03-22 4:42 pm |
N/A 2030-01-05 |
Mirati Therapeutics Inc. | MRTX | Hickey Benjamin EVP, Chief Commercial Officer |
2,369 | $0 | 56,928 (Direct) |
View |
| 2021-03-19 Exercise |
2021-03-22 4:42 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | Hickey Benjamin EVP, Chief Commercial Officer |
2,369 | $114.33 | 56,928 (Direct) |
View |
| 2021-03-09 Exercise |
2021-03-10 9:30 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | Braslyn Ltd. LEWIS JOSEPH 10% Owner |
12,381 | $0.001 | 10,292,456 (Direct) |
View |
| 2020-03-09 Exercise |
2021-03-10 9:30 pm |
2017-01-06 N/A |
Mirati Therapeutics Inc. | MRTX | Braslyn Ltd. LEWIS JOSEPH 10% Owner |
12,381 | $5.599 | 10,292,456 (Direct) |
View |
| 2021-03-05 Exercise |
2021-03-09 9:48 pm |
N/A N/A |
Mirati Therapeutics Inc. | MRTX | Boxer Capital LLC Boxer Asset Management Inc. LEWIS JOSEPH MVA Investors LLC Davis Aaron I. LIEBERBURG IVAN M Dissanayake Shehan Bharatha Fuglesang Christopher 10% Owner |
611,440 | $0.001 | 2,332,809 (Direct) |
View |
| 2021-03-05 Exercise |
2021-03-09 9:48 pm |
2017-01-06 N/A |
Mirati Therapeutics Inc. | MRTX | Boxer Capital LLC Boxer Asset Management Inc. LEWIS JOSEPH MVA Investors LLC Davis Aaron I. LIEBERBURG IVAN M Dissanayake Shehan Bharatha Fuglesang Christopher 10% Owner |
142,801 | $5.599 | 2,332,809 (Direct) |
View |
| 2021-03-05 Exercise |
2021-03-09 9:48 pm |
2017-11-20 N/A |
Mirati Therapeutics Inc. | MRTX | Boxer Capital LLC Boxer Asset Management Inc. LEWIS JOSEPH MVA Investors LLC Davis Aaron I. LIEBERBURG IVAN M Dissanayake Shehan Bharatha Fuglesang Christopher 10% Owner |
468,639 | $13 | 2,332,809 (Direct) |
View |